Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer (FOLERO) : A Prospective Cohort Study to Determine the Effect of Frailty on Survival and to Assess Early Reversal of Temporary Intestinal Stoma

NCT06298877 is registered in ClinicalTrials.gov with Sahar Salehi as lead sponsor.

NCT NCT06298877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06298877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer (FOLERO) : A Prospective Cohort Study to Determine the Effect of Frailty on Survival and to Assess Early Reversal of Temporary Intestinal Stoma
Lead sponsor
Sahar Salehi
Phase
Not applicable
Overall status
Recruiting
Start date
March 11, 2024
Completion date
March 28, 2031
Enrollment
475 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer